Critically, there has been a welcome realisation that research and innovation must be a key cornerstone of modern cancer control, with an undeniable body of evidence, indicating that those cancer patients who are treated in research‐active hospitals or centres achieve better outcomes than those who are not. Embedding this plan within the framework of the EU Cancer Mission would be transformative for cancer survivors and society.ĭespite the undoubted progress that has been made in improving cancer control and increasing cancer survivorship over the last 50 years, the significant challenges that still persist across the cancer continuum have led to a renewed global focus on a disease that kills over 10 million citizens worldwide each year ( ). To achieve this, we propose the development of a clearly articulated and sustainably funded European Cancer Survivorship Research and Innovation Plan. Here, we aim to redress this balance, by identifying the key challenges in cancer survivorship research that need to be addressed and proposing a series of recommended solutions, which, if acted upon, would deliver significant benefits for the nearly 20 million cancer survivors in Europe. Previous research efforts have focussed more on the diagnosis and treatment of cancer, whereas cancer survivorship, to date, has been overlooked. However, from a research perspective, in order to fully realise these benefits, we need to ensure that all aspects of the cancer continuum are addressed. Harnessing these twin pillars of cancer research and cancer control can be transformative for the European cancer community and in particular for the European cancer patient.
The EU Cancer Mission and the European Beating Cancer Plan together provide an unrivalled opportunity to make significant inroads into a disease that kills over 1.7 million European citizens annually. We have reached a watershed moment in Europe in our efforts to ensure increased survival and better outcomes for cancer patients.
0 kommentar(er)
